A

Amboss

Evidence-based medical knowledge platform for clinicians

Junior Sales Manager DACH

Full-Time
No salary listed
Junior
Remote in Germany+2 moreMore locations: Cologne, Germany | Berlin, Germany
Remote
Sales & Account ManagementAccount Executive

About the job

Requirements
  • At least 1–2 years of experience in business-to-business sales, ideally including full-cycle exposure such as an Account Executive or mixed role.
  • Experience conducting independent outbound activity and building a sales pipeline from scratch.
  • Ability to speak with decision-makers and explain product value in their language.
  • Fluency in German at C1 level or above and good English skills.
  • A structured work approach for managing a pipeline with many parallel conversations.
  • Proficiency with a customer relationship management system such as HubSpot, Salesforce, or similar.
  • Interest in travel, education, healthcare, and nursing; a clinical background is not required.
Responsibilities
  • Own the full sales cycle for nursing schools from initial outreach through contract closure.
  • Build a pipeline of nursing schools through outbound calls, emails, and events.
  • Conduct product demonstrations for school directors and teaching staff, showing how Novaheal fits their curriculum.
  • Negotiate and close deals, then transfer new accounts cleanly to the Account Manager.
  • Maintain accurate customer relationship management records so the team can forecast and identify effective approaches.
  • Collect feedback from nursing schools and communicate it to Product to help shape the roadmap.
  • Test new outreach approaches and share the results with the team.

About the company

AMBOSS provides a medical knowledge platform used by students and clinicians. It combines an interactive library and high-yield question bank for students to study and prep for exams with a clinical decision support system for clinicians to guide patient care using evidence-based recommendations. The platform works online: users search and study from the medical library, practice with questions, and access point-of-care guidance and clinical decision support at the bedside or in clinics. AMBOSS differentiates itself through its physician-founded approach, a global team of physicians, scientists, and engineers, and its breadth of content that serves over a million healthcare professionals in 180+ countries, integrating both learning tools and real-time clinical guidance in one platform. The company aims to improve medical knowledge and clinical decision-making worldwide, helping physicians provide better patient care.

Company Size

1,001-5,000

Company Stage

Late Stage VC

Total Funding

$302M

Headquarters

Berlin, Germany

Founded

2012

Get referred to Amboss

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • AMBOSS launched AI Mode Learning in 2026, expanding daily usage beyond exam prep.
  • The March 2025 €240 million round funds international expansion and selective acquisitions.
  • August 2026 updates and global reach support product depth across 180 countries.

What critics are saying

  • OpenAI, Google, and Epic compress medical search into general-purpose copilots by 2027.
  • UpToDate and clinical AI vendors can undercut AMBOSS in hospital purchasing cycles.
  • If AMBOSS loses clinical-care relevance, it reverts to a student-only subscription business.

What makes Amboss unique

  • AMBOSS spans learning, clinical care, and teaching in one medical platform.
  • Its 2026 AI Mode pairs curated guidelines with inline citations and limits.
  • Physician-built content and 22,000+ questions create a trusted workflow moat.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Mental Health Support
  • Flexible Work Hours
  • Remote Work Options
  • Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
deutsche-startups.de
Jul 30th, 2025
Amboss Raises €240M, Valued at €800M

STARTUPLAND is set for November 5 at Cologne's RheinEnergieStadion, featuring talks, pitches, and networking. Key speakers include Sievert Weiss of Amboss, which raised €240 million at an €800 million valuation, and Shikha Ahluwalia from Balderton Capital, focusing on mental health. Sven Lackinger of Sastrify will discuss challenges in scaling. The event includes a pitch stage for young startups and is part of the RISE in STARTUPLAND-Week, turning Cologne into a startup hub.

Burda Principal Investments
May 13th, 2025
AMBOSS: Transforming Healthcare with AI Support

BPI has invested in AMBOSS, a platform evolving from a medical student tool to an AI-supported clinical companion for healthcare professionals. With over 1 million users globally, AMBOSS is expanding in the US and DACH regions. The company operates a hybrid B2C/B2B model, showing strong growth and profitability. AMBOSS is also expanding into new markets and roles, leveraging AI for reliable clinical decision-making. The investment supports AMBOSS's mission to enhance healthcare outcomes.

Handelsblatt
Apr 24th, 2025
Amboss Targets Global Expansion with Funding

Amboss, a medical learning platform, is aiming to become a market leader by raising significant funds, more than most healthtech startups. The new capital will also be used for acquisitions, with a key focus on expanding in the USA.

deutsche-startups.de
Apr 16th, 2025
Amboss secures €240M investment round

In Q1 2025, over €2.5 billion was invested in more than 40 startups. Notable investments include Finn, Amboss, and Solaris. Finn received up to €1 billion from Citi, Jefferies, and Avellinia Capital. Amboss secured €240 million from Kirkbi, M&G Investments, Lightrock, and existing investors, valuing the company at €800 million. Solaris attracted investment from SBI Group and Boerse Stuttgart Group.

deutsche-startups.de
Mar 25th, 2025
Amboss raises €240 million funding

Amboss has raised €240 million in a funding round led by Kirkbi, MG Investments, and Lightrock, with existing investors also participating. The Berlin-based EdTech company is now valued at approximately €800 million. The new capital will be used to expand into international markets and enhance offerings for healthcare professionals.